Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Varicella Zoster Virus Infection during Chemotherapy in Solid Cancer Patients

Authors
Kim, Seung TaePark, Kyong HwaOh, Sang CheulSeo, Jae HongShin, Sang WonKim, Jun SukKim, Yeul Hong
Issue Date
2012
Publisher
KARGER
Keywords
Solid cancer; Varicella zoster virus; Chemotherapy
Citation
ONCOLOGY, v.82, no.2, pp.126 - 130
Indexed
SCIE
SCOPUS
Journal Title
ONCOLOGY
Volume
82
Number
2
Start Page
126
End Page
130
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/106264
DOI
10.1159/000334739
ISSN
0030-2414
Abstract
Background: Varicella zoster virus (VZV) infection is a representative opportunistic infection in patients with hematological malignancies, with a high incidence of 30-50%. Many studies on the risk factors of VZV infection in this patient group have been conducted. However, few data have been reported exploring VZV infection during systemic chemotherapy in solid cancer patients. Patients and Methods: We retrospectively analyzed 92 patients diagnosed with VZV infection between April 2001 and July 2010 during systemic chemotherapy for solid tumors. All patients had received antiviral prophylaxis for VZV. Results: The median age at the time of diagnosis of VZV infection was 60.8 years (range 30.1-83.0) and the majority of patients (79.3%) did not have comorbidities. Eighty-one patients (88%) received chemotherapy for locally advanced or metastatic/recurrent disease and 11 (12.0%) had adjuvant chemotherapy after curative resection. Of 92 patients, 14 (15.2%) had non-small cell lung cancer and 10 (10.9%) breast cancer. All patients had a median of 2 metastatic lesions (range 0-4). At the time of diagnosis, 55 patients (59.8%) were receiving first-line chemotherapy and 15 (16.3%) more than third-line chemotherapy. The mean white blood cell, platelet and albumin level was 5,736/mu l, 205.7 x 10(3) and 3.8 mg/dl, respectively. On analysis for disease evaluation at the time nearest to diagnosis of VZV infection, only 14 patients (15.2%) revealed tumor response to chemotherapy. After the diagnosis of VZV infection, all patients were treated with antiviral agents. None of the patients experienced failure of therapy for VZV. Conclusion: We reported VZV infection during systemic chemotherapy in solid cancer patients. Patients may have a relatively poor tumor response to chemotherapy at the time nearest to diagnosis of VZV infection. A prospective or matched controlled trial is needed to confirm this finding. Copyright (C) 2012 S. Karger AG, Basel
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles
Graduate School > Department of Biomedical Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Seo, Jae Hong photo

Seo, Jae Hong
의과학과
Read more

Altmetrics

Total Views & Downloads

BROWSE